- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00919620
Stage-specific Case Management for Early Psychosis
Outcome of Stage-specific Early Intervention for Psychosis in Hong Kong: A Randomized Controlled Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Psychotic disorder is a debilitating illness which imposes substantial impact to the patients, their families, and the society. The provision of early intervention provides a window of opportunity to minimize the social and economic burden incurred by the illness.
Many previous studies of effectiveness of early intervention used the historical control approach and are subjected to cohort effects. For example, change of medication pattern over time could potentially lead to differences in outcome. In addition, few studies provide longer-term outcome data of treatment program beyond two years. The optimal length of intervention has not been determined, and many programmes used 12-24 month intervention mainly based on resources available. It is also important to ask whether favorable effects of early intervention could be sustained over time. Further analyses will be done to assess whether EI effects are more pronounced in particular subgroups including DUP, age, sex and diagnosis.
The proposed study aims to address these issues by using a randomized controlled design to investigate the longer-term (4 year) outcome of patients with first episode psychosis. The study randomizes 360 patients with first episode psychotic disorders into 3 groups: (1) standard care (outpatient based care with inpatient and community care as required); (2) standard care with 2 years of add-on stage specific case-management (individualized care delivered by designated case managers according to specific protocol); and (3) standard care with 4 years of add-on stage specific case management.
The study hypothesis are: (1) both 2 years and 4 years of case management produce better outcomes than standard care alone; (2) 4 years of case management produces better outcome than 2 years of case management.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hong Kong, China
- The University of Hong Kong
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- DSM-IV diagnosis of schizophrenia, schizoaffective disorder, schizophreniform psychosis, brief psychosis, psychosis nos or delusional disorder
- Cantonese-speaking Chinese
- Ability to understand the nature of the study and sign informed consent
- Capacity to participate in cognitive testing
Exclusion Criteria:
- Organic Brain disorder
- Known history of intellectual disability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: case management (4 yrs)
4-year case management and standard care
|
Stage-specific case-management for psychosis by designated key-workers according to specified protocol
|
Active Comparator: case management (2 yrs) and standard care (2 yrs)
2-year case management and standard care
|
Stage-specific case-management for psychosis by designated key-workers according to specified protocol
|
No Intervention: standard care (4 yrs)
standard care for 4 years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Functioning (social and occupational)
Time Frame: baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Psychotic symptoms
Time Frame: baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Psychotic symptoms will be assessed using the Positive and Negative Syndrome Scale (PANSS)
|
baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Psychotic symptoms
Time Frame: baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Psychotic symptoms will be assessed using Scale for the Assessment of Positive Symptoms (SAPS)
|
baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Psychotic symptoms
Time Frame: baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Psychotic symptoms will be assessed using Scale for the Assessment of Negative Symptoms (SANS).
|
baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Depressive symptoms
Time Frame: baseline, 12-month, 24-month, 36-month, 48-month
|
Depressive symptoms will be assessed using the Calgary Depression Scale for Schizophrenia (CDSS).
|
baseline, 12-month, 24-month, 36-month, 48-month
|
Neurocognitive functioning
Time Frame: baseline, 12-month, 24-month, 36-month, 48-month
|
A battery of neurocognitive tests will be conducted, including Handedness, Trail Making, Wisconsin Card Sorting Test, Semantic Verbal Fluency, Logical Verbal Memory, Visual Patterns Test, Letter Number Span, Monotone Counting, and Soft Neurological Signs.
|
baseline, 12-month, 24-month, 36-month, 48-month
|
Health economics
Time Frame: baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
baseline, 6-month, 12-month, 24-month, 36-month, 48-month
|
Collaborators and Investigators
Publications and helpful links
General Publications
- Hui CLM, Wong AKH, Ho ECN, Lam BST, Hui PWM, Tao TJ, Chang WC, Chan SKW, Lee EHM, Suen YN, Lam MML, Chiu CPY, Li FWS, Leung KF, McGhee SM, Law CW, Chung DWS, Yeung WS, Yiu MGC, Pang EPF, Tso S, Lui SSY, Hung SF, Lee WK, Yip KC, Kwan KL, Ng RMK, Sham PC, Honer WG, Chen EYH. Effectiveness and optimal duration of early intervention treatment in adult-onset psychosis: a randomized clinical trial. Psychol Med. 2022 Feb 11:1-13. doi: 10.1017/S0033291721004189. Online ahead of print.
- Puntis S, Minichino A, De Crescenzo F, Cipriani A, Lennox B, Harrison R. Specialised early intervention teams for recent-onset psychosis. Cochrane Database Syst Rev. 2020 Nov 2;11(11):CD013288. doi: 10.1002/14651858.CD013288.pub2.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- jcep-rct
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychotic Disorders
-
Medical College of WisconsinCompletedSchizophrenia | Affective Disorders | Psychotic Disorder | Psychotic Mood Disorder
-
Søren Dinesen ØstergaardCompletedAffective Disorders, PsychoticDenmark
-
Instituto de Investigación Hospital Universitario...CompletedSchizophrenia and Disorders With Psychotic Feature | Psychotic EpisodeSpain
-
University of MinnesotaUniversity of California, San FranciscoCompletedPsychotic Disorders | Schizophrenia | Schizoaffective Disorder | Cognitive Impairment | Psychosis | Treatment | Psychotic Depression | Psychotic Episode | Active Control | Psychotic Mood DisordersUnited States
-
VA Office of Research and DevelopmentNot yet recruitingMI-CBTech: A Mobile Intervention for Community Integration in Homeless-Experienced Veterans With SMIHomelessness | Schizophrenia Spectrum Disorders | Psychotic Mood Disorders | Psychotic Affective Disorders | Ill-Housed PersonsUnited States
-
Instituto de Investigación Hospital Universitario...Carlos III Health Institute; European Regional Development FundCompletedSchizophrenia and Disorders With Psychotic Features | Psychotic EpisodeSpain
-
Centre hospitalier de Ville-Evrard, FranceRecruiting
-
University Hospital, CaenRecruiting
-
University of California, San DiegoActive, not recruitingSchizophrenia | Schizoaffective Disorder | Mood Disorder, PsychoticUnited States
-
Boston Medical CenterNational Institute of Mental Health (NIMH); Beth Israel Deaconess Medical CenterCompletedPsychotic Disorders | Psychosis | Psychotic EpisodeUnited States
Clinical Trials on stage-specific case-management
-
Brown UniversityUniversity of California, Los Angeles; National Institute of Nursing Research... and other collaboratorsRecruiting
-
Brown UniversityThe Miriam HospitalCompletedOptimizing PrEP Uptake & Adherence Among Male Sex Workers (MSW) Using a 2-stage Randomization DesignPreventionUnited States
-
University of California, Los AngelesBrown UniversityRecruitingPreventionUnited States
-
National Taiwan University HospitalCompleted
-
Minneapolis Veterans Affairs Medical CenterCompletedDiabetes MellitusUnited States
-
New York State Psychiatric InstituteEmory UniversityCompletedDepressive Disorder | Bipolar Disorder | Mental Disorders, Severe | Schizophrenia and Related Disorders
-
Johns Hopkins UniversityJohns Hopkins Community PhysiciansWithdrawnSubstance-related DisorderUnited States
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Kaiser PermanenteNot yet recruiting